Table 1 The performance of TAGMe assessment stratified by different clinical characteristics
Clinical characteristics | TAGMe positive | Urothelial Carcinoma | Sensitivity (95% CI) |
|---|---|---|---|
Invasiveness | |||
 NMIUC | 211 | 247 | 85.4% (80.4–89.6%) |
 MIUC | 120 | 130 | 92.3% (86.3–96.3%) |
Grade | |||
 Low grade | 75 | 97 | 77.3% (67.7–85.2%) |
 High grade | 231 | 253 | 91.3% (87.1–94.5%) |
Tumor numbers | |||
 Single | 149 | 171 | 87.1% (81.2–91.8%) |
 Multiple | 129 | 148 | 87.2% (80.7–92.1%) |
Tumor size | |||
 < 1 cm | 32 | 38 | 84.2% (68.8–94.0%) |
 1–3 cm | 145 | 169 | 85.8% (79.6–90.7%) |
 > 3 cm | 92 | 102 | 90.2% (82.7–95.2%) |